Patents by Inventor Peter Hellings

Peter Hellings has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Probiotic strain and its uses
    Patent number: 11813297
    Abstract: The present invention is directed to a novel isolated bacterial strain of the Lactobacillus casei (L. casei) species. More in particular, the strain of the Lactobacillus casei species deposited under accession number LMG P-30039. The present invention further relates to the novel L. casei strain for use in the treatment and/or prevention of infections and/or immune-related diseases. Also the use of the isolated novel L. casei strain or a composition comprising said strain as an adjuvant to promote an immune response during vaccination is disclosed. Further, the use of said novel L. casei strain or a composition comprising said strain in personal hygiene industry, cleaning industry, biomass production, air purification and food industry is disclosed. In another aspect of the present invention, the use of a L. casei species that has a whole genome G/C content of at least 47.5% and expresses one or more catalase genes or a composition comprising one or more of said L.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: November 14, 2023
    Assignees: Katholieke Universiteit Leuven, KU Leuven R & D, Universiteit Antwerpen
    Inventors: Camille Allonsius, Ilke De Boeck, Stijn Wittouck, Sander Wuyts, Sarah Lebeer, Peter Hellings
  • A NOVEL PROBIOTIC LACTOBACILLUS CASEI STRAIN AND ITS USES
    Publication number: 20210128648
    Abstract: The present invention is directed to a novel isolated bacterial strain of the Lactobacillus casei (L. casei) species. More in particular, the strain of the Lactobacillus casei species deposited under accession number LMG P-30039. The present invention further relates to the novel L. casei strain for use in the treatment and/or prevention of infections and/or immune-related diseases. Also the use of the isolated novel L. casei strain or a composition comprising said strain as an adjuvant to promote an immune response during vaccination is disclosed. Further, the use of said novel L. casei strain or a composition comprising said strain in personal hygiene industry, cleaning industry, biomass production, air purification and food industry is disclosed. In another aspect of the present invention, the use of a L. casei species that has a whole genome G/C content of at least 47.5% and expresses one or more catalase genes or a composition comprising one or more of said L.
    Type: Application
    Filed: March 23, 2018
    Publication date: May 6, 2021
    Applicants: KU Leuven Research & Development, Universiteit Antwerpen
    Inventors: Camille Allonsius, Ilke De Boeck, Stijn Wittouck, Sander Wuyts, Sarah Lebeer, Peter Hellings